Health

STAT+: Pharmalittle: We’re reading about a Merck AI deal, China and the pharma supply chain, and more

The partnership — only the latest such deal between a pharma giant and Isomorphic — will join Isomorphic’s proprietary drug design engine and existing wet lab data from Merck, which will handle the preclinical and clinical development, manufacturing, and commercializing of any products.

✦ Extractive summary — built from the sources' own reporting•From 1 source•1 min read•Updated November 19, 2026, 1:36 PM UTC
Key points
  • … Merck and Isomorphic Labs, the artificial intelligence drug designer built on a Nobel-winning technology that can model how molecules will bind to proteins, are entering into a research collaboration to discover small molecule candidates for an undisclosed oncology target of “strategic importance,” STAT reports.
  • Food and Drug Administration approved a Sanofi drug, making ​it the first treatment for a ‌type of rare genetic condition that affects the brain and nervous system, Reuters writes.
  • As for the official mascots, they have finished keeping passersby at bay and are now happily snoozing in their respective corners.

The drug, ​branded as Infilbray, was approved for ​adults and children weighing at least ⁠15 kilograms, or about 33 pounds, ​with type 3 Gaucher disease, a ​rare inherited disorder that causes fatty substances to build up in the body and brain.

Additional details
  • And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us.
  • Continue to STAT+ to read the full story….
  • As for us, we are firing up the trusty kettle for another cup of stimulation.
  • Our choice today is peppermint, an old standby from our pantry.
  • Rise and shine, everyone, another busy day is on the way.

How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →

Advertisement

Every article behind this summary — 1 article from 1 outlet